Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Mur d'écrans de télévision

Press Room

Resources dedicated to journalists and media professionals

The PR department responds to all media requests for information on scientific, medical, technological and entrepreneurial activities at Paris Brain Institute.

It disseminates new results from research teams and connects journalists to a relevant expert to comment on a current issue.

Feel free to contact our press officer to help you develop a topic that relies on state-of-the-art knowledge in neuroscience, neurology or psychiatry.

Press contact
Marie Simon
Email : presse@icm-institute.org

Our press documents

image neurones corticaux
Oxygen therapy subsides abnormal movements in a rare childhood disease
Researchers led by Emmanuel Flamand-Roze, at Paris Brain Institute, have shown that a simple administration of oxygen can alleviate abnormal movement attacks in an orphan disease – alternating hemiplegia of childhood (AHC). These encouraging...
02.21.2023 Research, science & health
neurones sensoriels
Sensory cells taste the cerebrospinal fluid to fight brain infections
Sensory neurons pick up information from our senses and relay it to the rest of the nervous system. But this is not their only mission. In a new study published in the journal Current Biology, Claire Wyart at Paris Brain Institute, and Christina...
02.20.2023 Research, science & health
Delphine OUDIETTE et Stéphanie BAULAC
Two researchers from the Paris Brain Institute rewarded by the 2022 ERC
The European Research Council (ERC) has just published the list of the winners of the grants it is about to distribute. This year, two researchers from at the Paris Brain Institute have been distinguished.
02.07.2023 Research, science & health
cognition
A subtitled world: uncovering tickertape synesthesia
The acquisition of reading and writing are complex mechanisms whose subtleties we do not yet understand. Fabien Hauw and Laurent Cohen (Inserm, CNRS, Sorbonne University, AP-HP), neurologists at Paris Brain Institute, hope to uncover how we connect...
02.03.2023 Research, science & health
lobes cerveau
Towards better management of disinhibition in frontotemporal dementia
Disinhibition is one of the main symptoms of the behavioural variant frontotemporal dementia (bvFTD), a type of dementia associated with degeneration of the frontal and temporal lobes of the brain. Patients with bvFTD exhibit behaviours that are...
01.30.2023 Research, science & health
image
New drug candidate slows the progression of adrenoleukodystrophy
The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective effects of...
01.20.2023 Research, science & health
image dépression
Ketamine and depression: a mechanism of the antidepressant effect reveal
Researchers from Inserm, CNRS, Sorbonne University and clinicians from the AP-HP and at Paris Brain Institute identified one of the mechanisms explaining ketamine effect as an antidepressant. Ketamine, usually used as an anesthetic, was administered...
10.06.2022 Research, science & health

Our useful documents

All

No results found

News that might interest you

Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
Julien SERUSCLAT
Julien Serusclat: effective writing for clinical trials
As a medical writer within the Neurotrials team, Paris Brain Institute’s early clinical development unit, Julien Serusclat uses his writing skills for the benefit of the scientific community. He develops the essential documents used in clinical...
11.05.2025 Portraits
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
La qualité des mitochondries durant le neurodéveloppement est cruciale pour la santé cérébrale
Mitochondrial quality during neurodevelopment is crucial for brain health
The anomalies underlying neurodegenerative diseases may arise during development—decades before the first symptoms appear. This hypothesis is gaining traction thanks to a new study published in Nature Communications. According to researchers from the...
10.20.2025 Research, science & health
Serge Weinberg © Simon Cassanas
Serge Weinberg appointed Chairman of Paris Brain Institute Board of Directors
Paris Brain Institute announces Serge Weinberg’s election as President of its Board of Directors. He succeeds Gérard Saillant, our Founding President, who becomes Honorary President after fifteen years of dedicated service to the Institute.
10.16.2025 Institutional
See all our news